Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Ascelia Pharma – Presentation of Full year and Q4 report

Af HC Andersen Capital
07.02.2025, 13.30
Ascelia Pharma

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Meet and ask questions to Deputy CEO Julie Waras Brogren from Ascelia Pharma on February 7th. at 1:30 PM.

In 2024, the company received positive headline data from the Orviglance SPARKLE Phase 3 study, along with the full data package from this study, which meets both the primary and secondary endpoints. At the same time, the company completed a capital increase to strengthen its financial position ahead of finalizing a partnership agreement. Key focus areas for 2025 include securing a partnership agreement and submitting an NDA application to FDA for the approval of Orviglance.

Ascelia Pharma is a biotech company focused on orphan oncology treatments. They develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. The company has two drug candidates – Orviglance® (Mangoral) and Oncoral – in clinical development. Ascelia Pharma has its global headquarters in Malmo, Sweden, and is listed on Nasdaq Stockholm (ticker: ACE)

Disclaimer: HC Andersen Capital receives payment from Ascelia Pharma for a DigitalIR/Corporate Visibility agreement./Claus Thestrup 10.30 23-01-2025

Recent videos

SO
Sea1 Offshore, Audiocast Q2'25
15.08.2025, 13.00 Sea1 Offshore
WI
WindowMaster – H1 2025 interim report
15.08.2025, 13.00 WindowMaster International
AKTIER MED FRIIS - UGE 33 2025
15.08.2025, 12.00
FGG
Fractal Gaming Group, Audiocast, Q2'25
15.08.2025, 11.00 Fractal Gaming Group
Bi
Bioporto - Præsentation af halvårsregnskabet for 2025
15.08.2025, 11.00 BioPorto
Vis alle videoer
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.

  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Privatlivspræferencer

Inderes bruger cookies for at give en bedre brugeroplevelse og en personlig service. Ved at give samtykke til brugen af cookies kan vi udvikle en endnu bedre service og vil kunne levere indhold, der er interessant for dig.